Alliance Pharma plc (LON:APH – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as GBX 61.50 ($0.75) and last traded at GBX 61.20 ($0.75), with a volume of 4399260 shares traded. The stock had previously closed at GBX 61.10 ($0.75).
Alliance Pharma Price Performance
The stock has a market cap of £330.83 million, a PE ratio of -1,020.00, a PEG ratio of 1.04 and a beta of 0.67. The business’s 50-day simple moving average is GBX 47.08 and its 200-day simple moving average is GBX 42.40. The company has a quick ratio of 1.42, a current ratio of 2.93 and a debt-to-equity ratio of 47.46.
Alliance Pharma Company Profile
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.
Read More
- Five stocks we like better than Alliance Pharma
- Breakout Stocks: What They Are and How to Identify Them
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- 3 Fintech Stocks With Good 2021 Prospects
- How Do Stock Buybacks Affect Shareholders?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
